MAPK3 and neoplasm: According to the in vitro data, sh-Tfeb D4M tumours showed reduced ERK1/2 activation, which was reported as the ratio of p-ERK1/2/ERK1/2 and an increase in DUSP-1 expression (Fig. 8A, B).